acute kidney injury
Conditions
Interventions
Integrated Traditional Chinese and Western Medicine Treatment Group:Yiqi Peiyuan granules and Western Medicine basic treatment
Sponsors
Renji Hospital Af?liated to Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Diagnosis of AKI based on KDIGO criteria; 2) Patient age between 18 and 75 years old; 3) Etiological diagnosis of renal AKI (such as drug-induced kidney injury infection progression of primary disease etc.); 4) Signed informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients with history of mental illness or those who are mentally confused unable to cooperate severely hypoxic restless and require emergency treatment; 2) Patients known to be allergic to the medication used; 3) Those currently participating in other drug clinical trials or who have taken traditional Chinese medicine compounds within the past week; 4) Those anticipated to require dialysis treatment within 72 hours after enrollment; 5) Patients with comorbid Stage 5 chronic kidney disease; 6) AKI considered to be caused by the use of ACEI/ARB medications; 7) Pregnant women; 8) Other situations where the investigator deems it inappropriate for the patient to participate in the trial
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| The change in eGFR from baseline.;Incidence of cardiovascular events;The change in creatinine from baseline.;Incidence of dialysis treatment;Change in Traditional Chinese Medicine (TCM) syndrome score from baseline;Metabolomics analysis; | — |
Primary
| Measure | Time frame |
|---|---|
| The change in eGFR from baseline.; | — |
Countries
China
Contacts
Public ContactShan Mou
Renji Hospital Af?liated to Shanghai Jiaotong University School of Medicine
Outcome results
None listed